(Reuters) – The U.S. Food and Drug Administration on Tuesday approved Springworks Therapeutics’ drug to treat a type of rare genetic disorder that causes tumors to grow on nerves throughout the body.
(Reporting by Christy Santhosh in Bengaluru; Editing by Mohammed Safi Shamsi)
Comments